Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09CZV
|
||||
| Former ID |
DNC002610
|
||||
| Drug Name |
Methyl Mercury Ion
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [551393] | ||
| Formula |
CH3Hg+
|
||||
| Canonical SMILES |
C[Hg+]
|
||||
| InChI |
1S/CH3.Hg/h1H3;/q;+1
|
||||
| InChIKey |
DBUXSCUEGJMZAE-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Carbonic anhydrase II | Target Info | Inhibitor | [551393] | |
| M-phase inducer phosphatase 2 | Target Info | Inhibitor | [551393] | ||
| Pathway Interaction Database | PLK1 signaling events | ||||
| FOXM1 transcription factor network | |||||
| p38 signaling mediated by MAPKAP kinases | |||||
| Aurora A signaling | |||||
| WikiPathways | Reversible Hydration of Carbon Dioxide | ||||
| Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | |||||
| Uptake of Oxygen and Release of Carbon Dioxide by ErythrocytesWP615:Senescence and Autophagy in Cancer | |||||
| MAPK Signaling Pathway | |||||
| Retinoblastoma (RB) in Cancer | |||||
| Prostate Cancer | |||||
| Integrated Breast Cancer Pathway | |||||
| Integrated Cancer pathway | |||||
| Mitotic G2-G2/M phases | |||||
| Cell Cycle | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.